Pam Rogaski

Pam Rogaski is an experienced clinical operations professional with a robust background in managing clinical studies. Currently serving as a Senior Manager at Neurocrine Biosciences since October 2014, Pam oversees a global phase 2 pediatric epilepsy study focused on a rare disease. In previous roles, particularly as Manager of Clinical Operations, Pam led study team activities to ensure adherence to standard operating procedures, FDA regulations, and ICH/GCP guidelines. Pam's career in clinical research began at Quintiles, where Pam held the position of Manager of Clinical Research from November 1995 to June 2014. Pam holds a B.A. in Biology from the University of California, Davis.